Cardiovascular and antithrombotic effects of ZK 96 480, a novel metabolically stable carbacyclin derivative with oral activity.
Stürzebecher
C S
CS
Research Laboratories, Schering AG Berlin/Bergkamen, W. Germany.
Loge
O
O
Schröder
G
G
Müller
B
B
Witt
W
W
D000244:Adenosine Diphosphate / Q000494:pharmacology; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects*; D011464:Epoprostenol / Q000494:pharmacology* / Q000627:therapeutic use / Q000031:analogs & derivatives; D005342:Fibrinolysis / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects*; D010974:Platelet Aggregation / Q000187:drug effects*; D051381:Rats; D011918:Rats, Inbred SHR; D013927:Thrombosis / Q000517:prevention & control*
D000244:Adenosine Diphosphate; D011464:Epoprostenol; C043867:cicaprost